Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Alaunos Therapeutics Inc

TCRT
Current price
2.02 USD -0.06 USD (-2.88%)
Last closed 2.16 USD
ISIN US98973P1012
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 266 550 USD
Yield for 12 month -85.94 %
1Y
3Y
5Y
10Y
15Y
TCRT
21.11.2021 - 28.11.2021

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas. Address: 2617 Bissonnet Street, Houston, TX, United States, 77005

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.75 USD

P/E ratio

Dividend Yield

Current Year

+5 000 USD

Last Year

+2 922 000 USD

Current Quarter

+4 000 USD

Last Quarter

+1 000 USD

Current Year

-2 310 000 USD

Last Year

+163 000 USD

Current Quarter

+3 000 USD

Last Quarter

-1 000 USD

Key Figures TCRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 579 000 USD
Operating Margin TTM -29150 %
PE Ratio
Return On Assets TTM -51.76 %
PEG Ratio
Return On Equity TTM -150.5 %
Wall Street Target Price 1.75 USD
Revenue TTM 7 000 USD
Book Value 2.36 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -19 596 000 USD
Earnings per share -319.97 USD
Diluted Eps TTM -319.97 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TCRT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TCRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 18.07.2024
Dividend Date

Stock Valuation TCRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 724.3565
Price Sales TTM 466.65
Enterprise Value EBITDA -3.5452
Price Book MRQ 0.8662

Financials TCRT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TCRT

For 52 weeks

2 USD 32.85 USD
50 Day MA 2.57 USD
Shares Short Prior Month 130 686
200 Day MA 10.11 USD
Short Ratio 4.56
Shares Short 132 342
Short Percent 9.6 %